ResearchMoz

GlobalData Market Research Reports

GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge.


GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

List of reports from GlobalData

Displaying 401 to 430 (of 10431 records)
Ethylene Industry Outlook in Korea to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013  
Ethylene Industry Outlook in Korea to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Ethylene Industry Outlook in Korea to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Korea Ethylene industry. The research presents major...
$1000
Ethylene Industry Outlook in the US to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013  
Ethylene Industry Outlook in the US to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Ethylene Industry Outlook in the US to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of The US Ethylene industry. The research presents...
$1000
Ethylene Industry Outlook in Russia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013  
Ethylene Industry Outlook in Russia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Ethylene Industry Outlook in Russia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Russia Ethylene industry. The research presents...
$1000
Propylene Industry Outlook in China to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013  
Propylene Industry Outlook in China to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Propylene Industry Outlook in China to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of China Propylene industry. The research presents...
$1000
Propylene Industry Outlook in Saudi Arabia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013  
Propylene Industry Outlook in Saudi Arabia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Propylene Industry Outlook in Saudi Arabia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Saudi Arabia Propylene industry. The...
$1000
Unconventional Gas (Gas Shales and Coal Bed Methane) - Global Market Analysis, Industry Developments, Investment Scenario and Forecasts to 2020
Feb 2013  
Unconventional Gas (Gas Shales and Coal Bed Methane) - Global Market Analysis, Industry Developments, Investment Scenario and Forecasts to 2020 Summary Unconventional Gas (Gas Shales and Coal Bed Methane) - Global Market Analysis, Industry Developments, Investment Scenario and Forecasts to 2020 is the latest report from GlobalData, the industry analysis specialist, and analyzes the...
$3995
Oil & Gas Monthly Deals Analysis January 2013: M&A and Investment Trends
Feb 2013  
Oil & Gas Monthly Deals Analysis January 2013: M&A and Investment Trends Summary GlobalData's Oil & Gas Monthly Deals Analysis January 2013: M&A and Investment Trends report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the oil and gas industry. The report provides detailed information on M&As,...
$1000
Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017
Feb 2013  
Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 Summary GlobalDatas energy offering, Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 is the essential source for industry data and information relating to the refining...
$5000
Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017
Feb 2013  
Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 Summary GlobalDatas energy offering, Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 is the essential source for industry data and...
$5000
Healthcare, Regulatory and Reimbursement Landscape - Egypt
Feb 2013  
Healthcare, Regulatory and Reimbursement Landscape - Egypt Summary GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Egypt. The report is an essential source of information and analysis on Egypts healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides...
$1995
Healthcare, Regulatory and Reimbursement Landscape - Colombia
Feb 2013  
Healthcare, Regulatory and Reimbursement Landscape - Colombia Summary Industry analysis specialist GlobalData has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Colombia. An essential source of information and analysis on the Colombian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and...
$1995
Healthcare, Regulatory and Reimbursement Landscape - Switzerland
Feb 2013  
Healthcare, Regulatory and Reimbursement Landscape - Switzerland Summary GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Switzerland. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in Switzerland.  It identifies key...
$1995
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction....
$4995
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction....
$4995
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022
Feb 2013  
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
$4995
Bronchiectasis Global Clinical Trials Review, H1, 2013
Feb 2013  
Bronchiectasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Bronchiectasis Global Clinical Trials Review, H1, 2013" provides data on the Bronchiectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchiectasis. It includes an overview of the trial numbers and...
$2500
Fabry Disease Global Clinical Trials Review, H1, 2013
Feb 2013  
Fabry Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Fabry Disease Global Clinical Trials Review, H1, 2013" provides data on the Fabry Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fabry Disease. It includes an overview of the trial numbers and their...
$2500
Regurgitation Global Clinical Trials Review, H1, 2013
Feb 2013  
Regurgitation Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Regurgitation Global Clinical Trials Review, H1, 2013" provides data on the Regurgitation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Regurgitation. It includes an overview of the trial numbers and...
$2500
Thromboembolism Global Clinical Trials Review, H1, 2013
Feb 2013  
Thromboembolism Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers...
$2500
Venous Thromboembolism Global Clinical Trials Review, H1, 2013
Feb 2013  
Venous Thromboembolism Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Venous Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism . It includes an...
$2500
Ventricular Tachycardia Global Clinical Trials Review, H1, 2013
Feb 2013  
Ventricular Tachycardia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Ventricular Tachycardia Global Clinical Trials Review, H1, 2013" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes...
$2500
Endotoxemia Global Clinical Trials Review, H1, 2013
Feb 2013  
Endotoxemia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Endotoxemia Global Clinical Trials Review, H1, 2013" provides data on the Endotoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endotoxemia. It includes an overview of the trial numbers and their...
$2500
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013
Feb 2013  
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an...
$2500
Hypoxemia Global Clinical Trials Review, H1, 2013
Feb 2013  
Hypoxemia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Hypoxemia Global Clinical Trials Review, H1, 2013" provides data on the Hypoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoxemia. It includes an overview of the trial numbers and their recruitment...
$2500
 
Displaying 401 to 430 (of 10431 records)